EPS for Mirati Therapeutics, Inc. (MRTX) Expected At $-0.78

Retrieved on: 2018-07-18 05:59:58

Tags for this article:

Finance

NASDAQ

Economy of the United States

Economy of New York City

Investment

AXL receptor tyrosine kinase

Sitravatinib

Click the tags to see associated articles and topics

EPS for Mirati Therapeutics, Inc. (MRTX) Expected At $-0.78. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> has invested 0% in Mirati Therapeutics, Inc. (NASDAQ:MRTX). Blackrock reported 634,234 shares. Thompson Davis ...</div>

Article found on:

View Original Article